LVLAVA Therapeutics N.V. LVTX · NASDAQ
$1.74 -3.87% (-$0.07)
- Market cap
- $45.8M
- Enterprise value
- -$3.89M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 9.2x
- P/FCF
- 3.2x
- EV/EBITDA
- -
- ROIC
- -47.4%
- Gross margin
- -392.0%
- Net margin
- -466.4%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 3.4x
- Beta
- 0.50
- Free float
- 46.9%
About the company
LAVA Therapeutics N.V. (LVTX) is a biopharmaceutical company specializing in the development of novel immunotherapeutic drugs. The company focuses on developing therapies that harness the natural abilities of the immune system to combat cancer and other diseases. LAVA Therapeutics focuses on researching and developing new treatment approaches, utilizing immune system-based technologies such as immune modulators and specific antigens. The company responds to the growing interest in new forms of cancer therapy and treatments based on the immune system. Shares of LAVA Therapeutics N.V. (LVTX) can be an interesting choice for investors tracking the biopharmaceutical and research sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Allen Hurly
Employees
34
Headquarters
Utrecht
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
- What to watch: It missed profit estimates 4 times in the last 8 quarters.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: Out of every 100 USD of revenue, 286 USD is left as free cash.
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What to watch: It passes only 2 of the 9 points of the Piotroski financial health test.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
- What speaks for it: The price moves less than the market (beta 0.50).
Statements
Every number